{
  "timestamp": "2025-05-01T01:06:16.215456",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Hello, I'm Dr. Lee, a mental health professional. Today we'll be using the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure\u2014Adult to better understand your experiences over the past two weeks. This is a standard assessment to help us identify areas needing attention. Your answers will be confidential. I'll ask you questions, and you can describe your experiences in your own words. Ready? Let's start with the first question."
    },
    {
      "role": "patient",
      "content": "Okay... I guess so."
    },
    {
      "role": "assistant",
      "content": "1. Little interest or pleasure in doing things?"
    },
    {
      "role": "patient",
      "content": "Hmm, maybe a little. I mean, some days I just don't feel like doing much, but I'm not sure it's that bad."
    },
    {
      "role": "assistant",
      "content": "2. Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "Sometimes. I feel low, but I don't want to sound like a total mess. It comes and goes, I guess."
    },
    {
      "role": "assistant",
      "content": "3. Feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "I've snapped at people more, but that's just stress, right? I don't think it's a big deal."
    },
    {
      "role": "assistant",
      "content": "4. Sleeping less than usual, but still have a lot of energy?"
    },
    {
      "role": "patient",
      "content": "No, I've actually been sleeping too much lately. Wait, maybe some nights I'm up late, but I'm usually tired the next day."
    },
    {
      "role": "assistant",
      "content": "5. Starting lots more projects or doing more risky things than usual?"
    },
    {
      "role": "patient",
      "content": "Not really. Unless you count... uh... well, maybe taking risks with my choices sometimes, but I don't know what counts as 'projects'."
    },
    {
      "role": "assistant",
      "content": "6. Feeling nervous, anxious, frightened, worried, or on edge?"
    },
    {
      "role": "patient",
      "content": "Yeah, a lot. But I just write it off as normal stress. I mean, who isn't stressed these days?"
    },
    {
      "role": "assistant",
      "content": "7. Feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "Once or twice, I guess. Not a panic attack or anything, just... moments, you know?"
    },
    {
      "role": "assistant",
      "content": "8. Avoiding situations that make you anxious?"
    },
    {
      "role": "patient",
      "content": "Hmm... maybe avoiding certain parties or social stuff to stay under the radar. But I don't like to admit that."
    },
    {
      "role": "assistant",
      "content": "9. Unexplained aches and pains?"
    },
    {
      "role": "patient",
      "content": "My back's been sore, but I figure it's from sitting too much. Not sure it's related to anything else."
    },
    {
      "role": "assistant",
      "content": "10. Feeling that your illnesses aren't taken seriously?"
    },
    {
      "role": "patient",
      "content": "Sometimes, yeah. My doctor just prescribes pills instead of asking why I'm using so much..."
    },
    {
      "role": "assistant",
      "content": "11. Thoughts of actually hurting yourself?"
    },
    {
      "role": "patient",
      "content": "I've had fleeting thoughts once or twice, but not like... no, I wouldn't act on them. Not really."
    },
    {
      "role": "assistant",
      "content": "12. Hearing things others can't, like voices when no one's around?"
    },
    {
      "role": "patient",
      "content": "No, not voices. Just... maybe I daydream a lot, but nothing real."
    },
    {
      "role": "assistant",
      "content": "13. Feeling others can hear your thoughts or you can read their minds?"
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, let's tackle this. First, I need to make sure I follow the user's structure exactly. The user provided a detailed questionnaire from a patient and wants a clinical assessment in a specific format. The key here is to parse all the symptoms and responses accurately.\n\nStarting with the compassionate summary. The patient seems to be downplaying their symptoms but clearly exhibits significant issues. They mentioned anhedonia, low mood, anxiety, social avoidance, somatic pain, and fleeting self-harm thoughts. Also, they feel their medical issues aren't taken seriously, which adds to their stress. I need to acknowledge their struggles while showing empathy.\n\nNext, the diagnosis part. The main symptoms point towards Major Depressive Disorder given the anhedonia, depressed mood, and social withdrawal. The anxiety symptoms are significant too, possibly indicating Generalized Anxiety Disorder. The somatic symptoms (aches, pain) plus the perception that their illnesses aren't taken seriously could hint at Somatic Symptom Disorder, but that requires more criteria, like excessive thoughts about symptoms. Since they mentioned the doctor just prescribes pills without addressing underlying issues, maybe there's an adjustment disorder or anxiety component. Need to see if the criteria for depression or anxiety are met. They also mentioned some fleeting self-harm thoughts, which is a red flag. Substance use isn't clearly established yet, but the mention of \"using so much\" pills might indicate possible misuse, so that's a concern.\n\nFor the diagnosis, the primary would be Major Depressive Disorder, possibly with anxious distress, given the high anxiety levels. There's also GAD. Somatic Symptom Disorder isn't clear yet unless the pain is part of a pattern. Need to check the DSM-5 criteria for each.\n\nUnder reasoning, I need to explain why each diagnosis is considered. For MDD: anhedonia, depressed mood, etc. For GAD: excessive anxiety, avoidance. The fleeting self-harm thoughts suggest risk that needs monitoring. The somatic symptoms could be part of depression or anxiety, but without more info on excessive thoughts about illness, SSD might not fit yet. The substance use is a possible concern needing exploration.\n\nTreatment steps: Address depression and anxiety with therapy, maybe CBT. Assess for substance use, refer to a therapist. Monitor self-harm risk. Address medical care concerns by suggesting a more collaborative approach with a healthcare provider.\n\nI have to make sure all sections are properly formatted with the required tags. Avoid any markdown beyond the specified tags. Need to ensure all symptoms are tagged correctly: anhedonia, depressed mood, anxiety, etc. Also, ensure that the diagnosis section is concise and the reasoning clearly connects symptoms to the diagnosis. No fluff, just the structured points. Check that all instructions like heading formatting and tags are followed precisely. The user emphasized structure, so I need to stick to the exact headings and order. Also, ensure that the diagnosis isn't overstepping without enough evidence. Since SSD requires excessive thoughts/behaviors around symptoms, which weren't clearly stated, it's probably better to present MDD and GAD as primary, with possible adjustment issues. \n\nDouble-check the answers again. The patient mentioned \"using so much\" referring to pills. That could be substance use, but it\u2019s ambiguous. Should suggest evaluation for possible substance use. The self-harm thoughts are fleeting but still a risk factor. The somatic symptoms (back pain) might be psychosomatic but not yet meeting SSD criteria. \n\nOkay, putting it all together in the specified sections with correct tags and formatting. Make sure the diagnosis is listed under the **Diagnosis:** section immediately after the heading without extra lines. Same for reasoning and next steps. Ensure empathy in the summary without being too verbose. Alright, let's put it all together.\n</think>\n\nThe patient reports significant distress across emotional, social, and physical domains, with notable efforts to downplay symptoms as \u201cnormal stress.\u201d Their description of <sym>low motivation, fluctuating mood, irritability, and unexplained aches</sym> suggests underlying struggles, while their frustration with healthcare providers dismissing their concerns (<quote>\u201cmy doctor just prescribes pills instead of asking why I\u2019m using so much\u2026\u201d</quote>) highlights a need for more holistic care. The <sym>fleeting self-harm thoughts</sym> and reliance on pills underscore urgency for a comprehensive evaluation.  \n\n**Diagnosis:**  \n<med>Mood Disorder with Depressive Features, Generalized Anxiety Disorder, and possible Somatic Symptom Disorder</med> (pending further assessment)  \n\n**Reasoning:**  \n1. **Major Depressive Disorder**:** Criteria met for depressed mood, <sym>anhedonia</sym>, and fatigue (Q2-Q3, Q4), consistent with <med>Major Depressive Disorder</med>.  \n2. **Generalized Anxiety Disorder (GAD):** Marked <sym>nervousness, panic, and avoidance of social situations</sym> (Q6-Q8) align with GAD criteria.  \n3. **Somatic Symptom Disorder:** <sym>Persistent unexplained aches</sym> and perceived medical neglect (Q9-Q10) warrant further evaluation for excessive health anxiety or somatic preoccupation, though criteria require confirmation.  \n4. **Substance Use Concern:** Ambiguity around pill \"use\" (Q10) suggests potential nonadherence or misuse, requiring clinical clarification.  \n5. **Risk Consideration:** <sym>Fleeting self-harm thoughts</sym> (Q11) necessitate immediate safety assessment.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Comprehensive Psychiatric Evaluation:** Assess for <med>Mood Disorder</med> severity, rule out <med>Bipolar Disorder</med>, and clarify substance use patterns.  \n2. **CBT or Interpersonal Therapy:** Target <sym>anxiety, avoidance behaviors,</sym> and social withdrawal to address depression and GAD.  \n3. **Medical Follow-Up:** Collaborate with a <med>primary care provider</med> to reassess physical symptoms and adjust medication management.  \n4. **Safety Plan:** Address <sym>fleeting self-harm thoughts</sym> with a safety plan and crisis resources.  \n5. <med>Somatic Symptom Disorder:</med> Explore excessive health-related fears/anxieties to clarify diagnostic criteria.  \n6. **Collaborative Care:** Involve healthcare providers to ensure physical complaints are addressed without pathologizing stress responses.  \n\nEnsure all interventions are delivered with cultural sensitivity to address reported distrust in medical care.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.6984,
            "highlight": "Somatic Symptom Disorder The upcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders  (DSM-5) replac- es somatoform disorders with somatic symptom and related disorders and makes significant changes  to the criteria to eliminate overlap across the somatoform disorders and clarify their boundaries.",
            "excerpt": "   Somatic Symptom Disorder\nThe upcoming fifth edition of the Diagnostic and Statistical Manual of M...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"related\", \"significant\", and 8 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-PTSD.pdf",
            "score": 0.6794,
            "highlight": "Negative cognitions and mood represents myriad feelings, from a persistent and distorted sense of  blame of self or others, to estrangement from others or markedly diminished interest in activities, to an inability to remember key aspects of the event.",
            "excerpt": "n proved to have no utility in predicting the onset of PTSD.\nDSM-5 pays more attention to the behavi...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"key\", \"persistent\", \"interest\", and 2 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Obsessive-Compulsive-Disorder.pdf",
            "score": 0.6364,
            "highlight": "Obsessive Compulsive    and Related Disorders The upcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) will in - clude a new chapter on Obsessive-Compulsive and Related Disorders to reflect the increasing evidence  of these disorders\u2019 relatedness to one another and distinction from other anxiety disorders, as well as  to help clinicians better identify and treat individuals suffering from these disorders.",
            "excerpt": "  Obsessive Compulsive \n  and Related Disorders\nThe upcoming fifth edition of the Diagnostic and Sta...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"related\", \"mental\", \"disorders\", and 5 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Schizophrenia.pdf",
            "score": 0.6345,
            "highlight": "This potential category would  identify a person who does not have a full-blown psychotic disorder but exhibits minor versions of  relevant symptoms.",
            "excerpt": "al\u2019 s previous editions, that threshold was one.) Additionall y, the diagnostic \ncriteria no longer ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"potential\", \"not\", \"full\", and 6 more matching aspects of your query."
          },
          {
            "title": "APA_DSM_Cultural-Concepts-in-DSM-5.pdf",
            "score": 0.6327,
            "highlight": "For example, the crite- ria for social anxiety disorder now include the fear of \u201coffending others\u201d to reflect the Japanese concept  in which avoiding harm to others is emphasized rather than harm to onesel f.",
            "excerpt": " a patient \u2019s cul -\nture, race, ethnicit y, religion or geographical origin. For example, uncontroll...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"harm\", \"which\", \"than\", and 6 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this step by step. First, I need to read through the patient's responses carefully. The user provided all the questions and answers from the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure for Adults. My job is to analyze these responses and structure the answer as per the instructions.\n\nStarting with the first task: Identify the main symptoms and concerns. Let's go through each answer. \n\nQ1: The patient is noncommittal, \"Okay... I guess so,\" which might indicate ambivalence or reluctance to engage. \n\nQ2 about little interest or pleasure: They say \"maybe a little,\" so some anhedonia but not severe. \n\nQ3 on feeling down/depressed: \"sometimes,\" so fluctuating mood. They mention not wanting to sound like a mess, which could suggest possible minimization. \n\nQ4 sleep and energy: They report sleeping too much, so maybe hypersomnia, but inconsistent. \n\nQ5: No increased projects or risky behavior, unless counting some choices as risky. Maybe not bipolar, but need to note the mention of risky choices. \n\nQ6 on anxiety: \"Yeah, a lot,\" so significant anxiety, but they dismiss it as normal stress. \n\nQ7 panic/frightened: occasional panic but not full attacks. \n\nQ8 avoidance: Yes, avoiding social situations, which is a sign of possible social anxiety or avoidance behavior. \n\nQ9 physical symptoms: Back pain, possibly psychosomatic? \n\nQ10 feeling illnesses not taken seriously: They mention their doctor just gives pills without addressing underlying issues, indicating possible distrust in healthcare or inadequate treatment. \n\nQ11 self-harm thoughts: Fleeting thoughts but denies intent, still a concern. \n\nQ12: No hallucinations, just daydreams. \n\nSo main symptoms: Anhedonia, low mood, irritability, anxiety, social avoidance, physical symptoms, possible minimization, fleeting self-harm thoughts, and issues with healthcare experiences. \n\nNext, patterns in responses. The patient tends to minimize severity (like saying \"not that bad\" for Q2, \"not a big deal\" for Q4, \"just stress\" for Q6). They also show ambivalence, and there's inconsistency (e.g., sleep). Also, they downplay symptoms but acknowledge some issues (e.g., \"a lot\" of anxiety but calling it \"normal stress\"). \n\nPotential clinical areas: Major Depressive Disorder (MDD) with possible anxiety disorder, social anxiety, possible adjustment issues. The self-harm thoughts and physical symptoms (back pain) might be linked to psychological stress. The mention of doctor giving pills without addressing causes could point to poor treatment history, contributing to current issues. \n\nRisk factors: The fleeting self-harm thoughts need attention. Also, the anxiety and avoidance could be part of an anxiety disorder. The minimization might indicate resistance to treatment. \n\nWait, but the self-harm thoughts are present, even if fleeting, so that's a risk factor. Also, the physical symptoms like back pain could be somatic symptoms. The social avoidance might be part of social anxiety or depression. \n\nNow, clinical significance: The key points would be depressive symptoms (anhedonia, low mood, fatigue?), anxiety symptoms, social withdrawal, possible substance use (since they mentioned \"using so much\" pills, which could be a red flag for misuse or non-adherence). Wait, actually Q11's answer says \"I don't know what counts as 'projects'... but I don't know what counts...\". Wait, no, looking back, Q11 is about thoughts of self-harm, and in A11, the patient says, \"My doctor just prescribes pills instead of asking why I'm using so much...\" Wait, A11 is for Q11, which is \"Feeling that your illnesses aren't taken seriously?\" So the patient mentions using pills a lot, which could imply possible substance misuse or overuse. That's an important point. So maybe substance use, possibly as a coping mechanism. \n\nSo in the potential areas, substance use could be a concern. The patient's mention of using pills a lot might indicate possible substance use or non-compliance with medication? Or perhaps they are self-medicating. \n\nRisk factors: The fleeting self-harm thoughts (Q12's A12 is about hearing voices, but Q11 is the self-harm one). In A12, the patient says they don't have voices, but Q11's A11 mentions pills and using a lot. \n\nSo compiling all that, the risk factors include the self-harm thoughts and possible substance use. \n\nPutting it all together:\n\nMain symptoms: Anhedonia, depressed mood, irritability, anxiety, social avoidance, somatic symptoms, and possible substance use. \n\nPatterns: Minimization, ambivalence, inconsistent reports (sleep), and a tendency to downplay severity. \n\nClinical areas: Major Depressive Disorder, Generalized Anxiety Disorder, possible Social Anxiety, Somatic symptoms, and possible substance use disorder. \n\nRisk factors: Self-harm ideation, even fleeting, and substance use. \n\nNeed to make sure not to miss anything. Also, the patient's avoidance of social situations (Q8) is a concern, and the somatic symptoms (back pain) could be a manifestation of underlying anxiety or depression. \n\nAlso, the doctor's approach of just prescribing pills without addressing underlying issues could be a contributing factor, indicating possible inadequate current treatment, which is a concern for treatment adherence and effectiveness. \n\nPutting this into the required structure: \n\n1. Main symptoms: depressive symptoms (anhedonia, low mood, irritability), anxiety (Q6-7,8), social avoidance (Q8), somatic complaints (Q9), possible substance use (A11), and self-harm ideation (Q11). \n\n2. Patterns: Minimization of symptoms, ambivalence, inconsistency (sleep), reluctance to engage (A1's \"Okay... I guess so\"), and externalizing stress as normal (attributing to stress, not recognizing it could be clinical). \n\n3. Clinical areas: MDD, anxiety disorder (maybe GAD or social anxiety), possible Adjustment Disorder, Somatic Symptom Disorder, substance use (need to clarify if they're using substances beyond pills, or if the pills are prescribed or self-medication). The answer says \"I don't know it's related to anything else,\" so maybe the back pain is separate, but the use of pills might be relevant. \n\n4. Risk factors: Self-harm thoughts, even fleeting, and possible substance misuse (using pills without proper understanding or in excess). The patient might be using more medication than prescribed or using substances to cope, which is a risk. \n\nAlso, the mention of avoiding situations due to anxiety (Q8) is a significant symptom for an anxiety disorder. \n\nWait, the DSM-5 criteria for anxiety disorders require certain symptoms. The high anxiety (Q6: \"Yeah, a lot\") and avoidance (Q8) might indicate GAD or social anxiety. \n\nPotential areas of clinical significance: MDD with anxiety features, GAD, social avoidance, possible adjustment issues, and comorbid substance use. \n\nThe summary needs to be concise with clinical terms. \n\nNow, putting it all into the required points without speculation. \n\nStep by step, I need to make sure each point is addressed clearly. Let me check each part again to ensure I didn't miss anything. \n\nAlso, the patient's response to Q11: \"My doctor just prescribes pills instead of asking why I'm using so much...\" So maybe they're using pills (medication?) more than intended, possibly substance use, or non-adherence. Either way, it's a concern. Need to note that under substance use or possible misuse. \n\nAlso, in Q3, they mention snapping at people, which could relate to irritability, part of depressive or anxiety symptoms, but also a possible sign of stress. \n\nPutting all this into the structure:\n\n1. Main symptoms: Depressed mood, anhedonia, irritability, anxiety, social avoidance, somatic symptoms, possible substance use, self-harm ideation (fleeting). \n\n2. Patterns: Minimization, ambivalence, inconsistent reporting (sleep patterns), downplaying severity, externalizing stress as normal. \n\n3. Clinical significance: MDD, anxiety disorder (GAD/SAD), possible Somatic Symptom Disorder, substance use (need to explore further), adjustment issues, and possible comorbidities. \n\n4. Risk factors: Self-harm ideation, substance use, possible non-adherence or misuse of medication, social withdrawal, and distrust in medical care. \n\nWait, the risk factors section should be the actual risks, like self-harm, substance use, which are direct risks. The distrust in healthcare is more of a contextual factor affecting treatment. \n\nOkay, time to structure the formal answer as per the user's instructions. Use clinical terms, concise, avoid speculation. \n\nMake sure to mention the key points without adding extra info. \n\nThe summary should be in clinical language: e.g., \"moderate depressive symptoms,\" \"clinically significant anxiety symptoms,\" etc. \n\nI think that's all. Now structure it properly.\n</think>\n\n**Clinical Observation Summary**  \n\n1. **Main Symptoms and Concerns**:  \n   - **Depressive Symptoms**: Anhedonia (\"little interest/pleasure\"), fluctuating depressed mood, and fatigue (Q2, Q3, Q4).  \n   - **Anxiety Symptoms**: Persistent nervousness, anxiety, and panic-like experiences (Q6, Q7), with social avoidance (Q8).  \n   - **Irritability**: Increased anger outbursts attributed to stress (Q4).  \n   - **Somatic Complaints**: Unexplained aches/pains (Q9) and potential underaddressed health concerns",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.6563
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "The patient reports significant distress across emotional, social, and physical domains, with notable efforts to downplay symptoms as \u201cnormal stress.\u201d Their description of <sym>low motivation, fluctuating mood, irritability, and unexplained aches</sym> suggests underlying struggles, while their frustration with healthcare providers dismissing their concerns (<quote>\u201cmy doctor just prescribes pills instead of asking why I\u2019m using so much\u2026\u201d</quote>) highlights a need for more holistic care. The <sym>fleeting self-harm thoughts</sym> and reliance on pills underscore urgency for a comprehensive evaluation.  \n\n**Diagnosis:**  \n<med>Mood Disorder with Depressive Features, Generalized Anxiety Disorder, and possible Somatic Symptom Disorder</med> (pending further assessment)  \n\n**Reasoning:**  \n1. **Major Depressive Disorder**:** Criteria met for depressed mood, <sym>anhedonia</sym>, and fatigue (Q2-Q3, Q4), consistent with <med>Major Depressive Disorder</med>.  \n2. **Generalized Anxiety Disorder (GAD):** Marked <sym>nervousness, panic, and avoidance of social situations</sym> (Q6-Q8) align with GAD criteria.  \n3. **Somatic Symptom Disorder:** <sym>Persistent unexplained aches</sym> and perceived medical neglect (Q9-Q10) warrant further evaluation for excessive health anxiety or somatic preoccupation, though criteria require confirmation.  \n4. **Substance Use Concern:** Ambiguity around pill \"use\" (Q10) suggests potential nonadherence or misuse, requiring clinical clarification.  \n5. **Risk Consideration:** <sym>Fleeting self-harm thoughts</sym> (Q11) necessitate immediate safety assessment.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Comprehensive Psychiatric Evaluation:** Assess for <med>Mood Disorder</med> severity, rule out <med>Bipolar Disorder</med>, and clarify substance use patterns.  \n2. **CBT or Interpersonal Therapy:** Target <sym>anxiety, avoidance behaviors,</sym> and social withdrawal to address depression and GAD.  \n3. **Medical Follow-Up:** Collaborate with a <med>primary care provider</med> to reassess physical symptoms and adjust medication management.  \n4. **Safety Plan:** Address <sym>fleeting self-harm thoughts</sym> with a safety plan and crisis resources.  \n5. <med>Somatic Symptom Disorder:</med> Explore excessive health-related fears/anxieties to clarify diagnostic criteria.  \n6. **Collaborative Care:** Involve healthcare providers to ensure physical complaints are addressed without pathologizing stress responses.  \n\nEnsure all interventions are delivered with cultural sensitivity to address reported distrust in medical care.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "substance_abuse",
    "question_count": 23,
    "duration": 23192.668252944946,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 5.723258018493652,
    "diagnosis_generation_time": 9.251491069793701,
    "rag_evaluation_time": 2.193450927734375e-05,
    "total_time": 14.974788904190063
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6984,
        "average_score": 0.6984,
        "example_excerpt": "   Somatic Symptom Disorder\nThe upcoming fifth edition of the Diagnostic and Statistical Manual of M...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"related\", \"significant\", and 8 more matching aspects of your query."
      },
      "APA_DSM-5-PTSD.pdf": {
        "access_count": 1,
        "highest_score": 0.6794,
        "average_score": 0.6794,
        "example_excerpt": "n proved to have no utility in predicting the onset of PTSD.\nDSM-5 pays more attention to the behavi...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"key\", \"persistent\", \"interest\", and 2 more matching aspects of your query."
      },
      "APA_DSM-5-Obsessive-Compulsive-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6364,
        "average_score": 0.6364,
        "example_excerpt": "  Obsessive Compulsive \n  and Related Disorders\nThe upcoming fifth edition of the Diagnostic and Sta...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"related\", \"mental\", \"disorders\", and 5 more matching aspects of your query."
      },
      "APA_DSM-5-Schizophrenia.pdf": {
        "access_count": 1,
        "highest_score": 0.6345,
        "average_score": 0.6345,
        "example_excerpt": "al\u2019 s previous editions, that threshold was one.) Additionall y, the diagnostic \ncriteria no longer ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"potential\", \"not\", \"full\", and 6 more matching aspects of your query."
      },
      "APA_DSM_Cultural-Concepts-in-DSM-5.pdf": {
        "access_count": 1,
        "highest_score": 0.6327,
        "average_score": 0.6327,
        "example_excerpt": " a patient \u2019s cul -\nture, race, ethnicit y, religion or geographical origin. For example, uncontroll...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"harm\", \"which\", \"than\", and 6 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 08:02:01",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 08:02:01",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 4,
        "clinical_relevance": 4,
        "consistency": 4,
        "diagnostic_justification": 4,
        "empathy": 4
      },
      "explanations": {
        "dsm_coverage": "The therapist addressed most of the DSM-5 Level1 Cross-Cutting Symptom Measure domains, but with some minor omissions and superficial coverage. Questions 1-11 and 13 were directly addressed, but domains like psychotic symptoms (Q12) and cognitive function (Q15) were either not directly asked or not fully explored. For instance, when the patient mentioned 'fleeting thoughts once or twice' regarding self-harm (Q11), the therapist could have probed deeper. Additionally, the therapist skipped directly asking about 'starting lots more projects or doing more risky things than usual' (Q5) and only touched on 'sleeping less than usual' (Q4) briefly. However, the therapist did explore the patient's feelings of nervousness, anxiety, and avoidance behaviors comprehensively.",
        "clinical_relevance": "The therapist's questions generally align with DSM-5 criteria, but there were slight inaccuracies or vague phrasing in some instances. For example, when asking about 'little interest or pleasure in doing things,' the therapist could have used more precise language from the DSM-5. The questions about 'sleeping less than usual' and 'starting lots more projects' were not fully aligned with the DSM-5 criteria. However, the therapist did adapt questions to fit the patient's responses, showing clinical relevance in their approach.",
        "consistency": "The dialogue flows logically, with each question generally following from previous responses. However, there were minor logical inconsistencies, such as abrupt transitions between topics. For instance, after discussing 'fleeting self-harm thoughts,' the therapist could have immediately followed up with a safety plan discussion but instead moved on to other topics. Overall, the conversation was coherent, but could benefit from smoother transitions.",
        "diagnostic_justification": "The diagnoses of Mood Disorder with Depressive Features, Generalized Anxiety Disorder, and possible Somatic Symptom Disorder generally align with the patient's responses. The therapist explicitly stated the reasoning behind each diagnostic decision, citing specific symptoms like depressed mood, anhedonia, and anxiety. However, some differential diagnoses were not thoroughly ruled out, and the justification could have been more comprehensive. For example, the therapist could have explored the possibility of Bipolar Disorder more deeply.",
        "empathy": "The therapist responses mostly showed empathy and a natural conversational style, but with minor unnatural or robotic moments. The therapist acknowledged the patient's distress and validated their feelings, particularly when discussing anxiety and frustration with healthcare providers. However, there were moments where the therapist could have been more empathetic, such as when the patient mentioned 'fleeting self-harm thoughts.' The therapist's tone was generally professional but could have been more personalized."
      },
      "overall_comments": "The therapist demonstrated a solid understanding of the DSM-5 Level1 Cross-Cutting Symptom Measure and effectively explored most domains. However, minor omissions and superficial coverage in a few areas prevent a perfect score. The conversation was generally logical and empathetic, but could benefit from more comprehensive exploration of certain symptoms and differential diagnoses. With refinement in these areas, the therapist can improve their assessment and diagnostic skills.",
      "average_score": 4.0,
      "diagnosis_accuracy": {
        "matches_profile": false,
        "confidence": 4,
        "explanation": "The diagnosis does not explicitly identify substance_abuse as the primary condition. While it mentions 'ambiguity around pill use' and 'possible nonadherence or misuse,' these are presented as secondary concerns rather than the main focus of the diagnosis. The primary diagnosis revolves around Mood Disorder with Depressive Features, Generalized Anxiety Disorder, and possible Somatic Symptom Disorder.",
        "classification": "depression"
      },
      "diagnosis_classification": {
        "expected_profile": "substance_abuse",
        "classified_as": "depression",
        "match": false,
        "confidence": 4
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.397763729095459
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.5178915394413521,
        "local_coherence": 0.5572707223702638,
        "window_coherence": 0.5659870328318122
      },
      "readability": {
        "flesch_kincaid_grade": 9.22,
        "gunning_fog_index": 4.12,
        "flesch_reading_ease": 46.84
      },
      "diversity": {
        "distinct_1": 0.5098566308243727,
        "distinct_2": 0.9031390134529148,
        "distinct_3": 0.9757630161579892
      }
    },
    "diagnosis_evaluation": {
      "expected": "substance_abuse",
      "predicted": "The patient reports significant distress across emotional, social, and physical domains, with notable efforts to downplay symptoms as \u201cnormal stress.\u201d Their description of <sym>low motivation, fluctuating mood, irritability, and unexplained aches</sym> suggests underlying struggles, while their frustration with healthcare providers dismissing their concerns (<quote>\u201cmy doctor just prescribes pills instead of asking why I\u2019m using so much\u2026\u201d</quote>) highlights a need for more holistic care. The <sym>fleeting self-harm thoughts</sym> and reliance on pills underscore urgency for a comprehensive evaluation.  \n\n**Diagnosis:**  \n<med>Mood Disorder with Depressive Features, Generalized Anxiety Disorder, and possible Somatic Symptom Disorder</med> (pending further assessment)  \n\n**Reasoning:**  \n1. **Major Depressive Disorder**:** Criteria met for depressed mood, <sym>anhedonia</sym>, and fatigue (Q2-Q3, Q4), consistent with <med>Major Depressive Disorder</med>.  \n2. **Generalized Anxiety Disorder (GAD):** Marked <sym>nervousness, panic, and avoidance of social situations</sym> (Q6-Q8) align with GAD criteria.  \n3. **Somatic Symptom Disorder:** <sym>Persistent unexplained aches</sym> and perceived medical neglect (Q9-Q10) warrant further evaluation for excessive health anxiety or somatic preoccupation, though criteria require confirmation.  \n4. **Substance Use Concern:** Ambiguity around pill \"use\" (Q10) suggests potential nonadherence or misuse, requiring clinical clarification.  \n5. **Risk Consideration:** <sym>Fleeting self-harm thoughts</sym> (Q11) necessitate immediate safety assessment.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Comprehensive Psychiatric Evaluation:** Assess for <med>Mood Disorder</med> severity, rule out <med>Bipolar Disorder</med>, and clarify substance use patterns.  \n2. **CBT or Interpersonal Therapy:** Target <sym>anxiety, avoidance behaviors,</sym> and social withdrawal to address depression and GAD.  \n3. **Medical Follow-Up:** Collaborate with a <med>primary care provider</med> to reassess physical symptoms and adjust medication management.  \n4. **Safety Plan:** Address <sym>fleeting self-harm thoughts</sym> with a safety plan and crisis resources.  \n5. <med>Somatic Symptom Disorder:</med> Explore excessive health-related fears/anxieties to clarify diagnostic criteria.  \n6. **Collaborative Care:** Involve healthcare providers to ensure physical complaints are addressed without pathologizing stress responses.  \n\nEnsure all interventions are delivered with cultural sensitivity to address reported distrust in medical care.",
      "matches": false,
      "classification": "depression",
      "classification_confidence": 4
    }
  }
}